114 related articles for article (PubMed ID: 29043907)
1. Prescription pattern and awareness of disease and treatment in patients of Parkinson's disease.
Tripathi RK; Kapse SV; Potey AV
Neurodegener Dis Manag; 2017 Oct; 7(5):299-306. PubMed ID: 29043907
[TBL] [Abstract][Full Text] [Related]
2. Prescribing patterns of antiparkinson drugs in a group of Colombian patients, 2015.
Machado-Alba JE; Calvo-Torres LF; Gaviria-Mendoza A; Castrillón-Spitia JD
Biomedica; 2018 Sep; 38(3):417-426. PubMed ID: 30335247
[TBL] [Abstract][Full Text] [Related]
3. Survey on general knowledge on Parkinson's disease in patients with Parkinson's disease and current clinical practice for Parkinson's disease among general neurologists from Southwest China.
Li J; Chen D; Song W; Chen K; Cao B; Huang R; Yang R; Shang H
Clin Neurol Neurosurg; 2014 Mar; 118():16-20. PubMed ID: 24529223
[TBL] [Abstract][Full Text] [Related]
4. Trends in inpatient antiparkinson drug use in the USA, 2001-2012.
Crispo JA; Fortin Y; Thibault DP; Emons M; Bjerre LM; Kohen DE; Perez-Lloret S; Mattison D; Willis AW; Krewski D
Eur J Clin Pharmacol; 2015 Aug; 71(8):1011-9. PubMed ID: 26081062
[TBL] [Abstract][Full Text] [Related]
5. Development and Validation of the Parkinson's Disease Medication Beliefs Scale (PD-Rx).
Fleisher JE; Dahodwala NA; Xie SX; Mayo M; Weintraub D; Chodosh J; Shea JA
J Parkinsons Dis; 2016 Apr; 6(2):383-92. PubMed ID: 27061070
[TBL] [Abstract][Full Text] [Related]
6. Discussing sexuality with patients with Parkinson's disease: a survey among Dutch neurologists.
van Hees PJ; van der Plas AA; van Ek GF; Putter H; Den Oudsten BL; den Ouden ME; Elzevier HW
J Neural Transm (Vienna); 2017 Mar; 124(3):361-368. PubMed ID: 27885433
[TBL] [Abstract][Full Text] [Related]
7. Knowledge, attitudes and perceptions of Parkinson's disease: A cross-sectional survey of Asian patients.
Jitkritsadakul O; Boonrod N; Bhidayasiri R
J Neurol Sci; 2017 Mar; 374():69-74. PubMed ID: 28104234
[TBL] [Abstract][Full Text] [Related]
8. Current clinical practice for Parkinson's disease among Chinese physicians, general neurologists and movement disorders specialists: a national survey.
Chen W; Chen S; Xiao Q; Wang G; Chen SD
BMC Neurol; 2012 Dec; 12():155. PubMed ID: 23216699
[TBL] [Abstract][Full Text] [Related]
9. Drug Safety Analysis in a Real-Life Cohort of Parkinson's Disease Patients with Polypharmacy.
Müller-Rebstein S; Trenkwalder C; Ebentheuer J; Oertel WH; Culmsee C; Höglinger GU
CNS Drugs; 2017 Dec; 31(12):1093-1102. PubMed ID: 29139041
[TBL] [Abstract][Full Text] [Related]
10. Antiparkinson drug use and adherence in medicare part D beneficiaries with Parkinson's disease.
Wei YJ; Palumbo FB; Simoni-Wastila L; Shulman LM; Stuart B; Beardsley R; Brown C
Clin Ther; 2013 Oct; 35(10):1513-1525.e1. PubMed ID: 24139423
[TBL] [Abstract][Full Text] [Related]
11. The use and potential abuse of anticholinergic antiparkinson drugs in Norway: a pharmacoepidemiological study.
Gjerden P; Bramness JG; Slørdal L
Br J Clin Pharmacol; 2009 Feb; 67(2):228-33. PubMed ID: 19094158
[TBL] [Abstract][Full Text] [Related]
12. Prescribing pattern and resource utilization of monoamine oxidase-B inhibitors in Parkinson treatment: comparison between rasagiline and selegiline.
Degli Esposti L; Piccinni C; Sangiorgi D; Nobili F; Buda S
Neurol Sci; 2016 Feb; 37(2):227-34. PubMed ID: 26474874
[TBL] [Abstract][Full Text] [Related]
13. Clinical features of Parkinson's disease patients are associated with therapeutic misconception and willingness to participate in clinical trials.
Reijula E; Pietilä AM; Halkoaho A; Selander T; Martikainen K; Kälviäinen R; Keränen T
Trials; 2017 Sep; 18(1):444. PubMed ID: 28962634
[TBL] [Abstract][Full Text] [Related]
14. Reluctance to start medication for Parkinson's disease: a mutual misunderstanding by patients and physicians.
Mestre TA; Teodoro T; Reginold W; Graf J; Kasten M; Sale J; Zurowski M; Miyasaki J; Ferreira JJ; Marras C
Parkinsonism Relat Disord; 2014 Jun; 20(6):608-12. PubMed ID: 24661467
[TBL] [Abstract][Full Text] [Related]
15. Socio-demographic and clinical factors influencing the adherence to treatment in Parkinson's disease: the ADHESON study.
Valldeoriola F; Coronell C; Pont C; Buongiorno MT; Cámara A; Gaig C; Compta Y;
Eur J Neurol; 2011 Jul; 18(7):980-7. PubMed ID: 21199185
[TBL] [Abstract][Full Text] [Related]
16. Prescribing patterns of antiparkinsonian agents in Europe.
Rosa MM; Ferreira JJ; Coelho M; Freire R; Sampaio C
Mov Disord; 2010 Jun; 25(8):1053-60. PubMed ID: 20222132
[TBL] [Abstract][Full Text] [Related]
17. Treatment of Parkinson's disease: a survey of patients and neurologists.
Fargel M; Grobe B; Oesterle E; Hastedt C; Rupp M
Clin Drug Investig; 2007; 27(3):207-18. PubMed ID: 17305415
[TBL] [Abstract][Full Text] [Related]
18. Factors determining when to start levodopa/carbidopa/entacapone treatment in Spanish patients with Parkinson's disease.
Martínez-Martín P; Hernández B; Ricart J;
Neurologia; 2014 Apr; 29(3):153-60. PubMed ID: 23465686
[TBL] [Abstract][Full Text] [Related]
19. Adherence to antiparkinson medication in a multicenter European study.
Grosset D; Antonini A; Canesi M; Pezzoli G; Lees A; Shaw K; Cubo E; Martinez-Martin P; Rascol O; Negre-Pages L; Senard A; Schwarz J; Strecker K; Reichmann H; Storch A; Löhle M; Stocchi F; Grosset K
Mov Disord; 2009 Apr; 24(6):826-32. PubMed ID: 19191340
[TBL] [Abstract][Full Text] [Related]
20. Early DEtection of wEaring off in Parkinson disease: the DEEP study.
Stocchi F; Antonini A; Barone P; Tinazzi M; Zappia M; Onofrj M; Ruggieri S; Morgante L; Bonuccelli U; Lopiano L; Pramstaller P; Albanese A; Attar M; Posocco V; Colombo D; Abbruzzese G;
Parkinsonism Relat Disord; 2014 Feb; 20(2):204-11. PubMed ID: 24275586
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
